TSXV - Delayed Quote CAD

Cannara Biotech Inc. (LOVE.V)

1.3200
-0.0200
(-1.49%)
At close: May 9 at 3:59:37 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Total Revenue
94,237.6250
81,747.5510
57,260.1930
35,841.3860
17,020.4070
Cost of Revenue
54,692.3350
51,960.8800
30,029.4680
18,510.1220
6,723.9060
Gross Profit
39,545.2900
29,786.6710
27,230.7250
17,331.2640
10,296.5010
Operating Expense
22,874.7310
21,742.1470
15,209.8440
12,355.5920
9,997.3000
Operating Income
16,670.5590
8,044.5240
12,020.8810
4,975.6720
299.2010
Net Non Operating Interest Income Expense
-4,971.6450
-5,473.2140
-5,007.4780
-3,221.6610
-1,672.8110
Other Income Expense
1,887.7070
1,912.6720
-67.9850
551.4080
-154.5330
Pretax Income
13,559.6210
4,483.9820
6,945.4180
2,305.4190
-1,528.1430
Tax Provision
188.3920
-1,954.5020
0
--
--
Net Income Common Stockholders
13,398.2290
6,438.4840
6,945.4180
2,305.4190
-1,528.1430
Diluted NI Available to Com Stockholders
13,398.2290
6,438.4840
6,945.4180
2,305.4190
-1,528.1430
Basic EPS
0.14
0.07
0.08
0.03
-0.10
Diluted EPS
0.14
0.07
0.08
0.03
-0.10
Basic Average Shares
90,152.5450
90,068.3830
89,300.4480
87,668.9540
76,515.1580
Diluted Average Shares
92,286.0700
91,385.0250
89,739.3630
87,840.4760
76,515.1580
Total Operating Income as Reported
18,708.3570
10,078.1510
11,887.7930
4,940.7350
257.2830
Rent Expense Supplemental
343.4540
326.7340
364.3560
307.9230
453.8400
Total Expenses
77,567.0660
73,703.0270
45,239.3120
30,865.7140
16,721.2060
Net Income from Continuing & Discontinued Operation
13,398.2290
6,438.4840
6,945.4180
2,305.4190
-1,528.1430
Normalized Income
11,536.7491
4,812.7128
7,013.4030
1,898.5350
-1,373.6100
Interest Income
218.3380
178.9630
239.5090
92.6930
52.7860
Interest Expense
4,213.3850
4,327.4680
3,883.3400
2,171.7260
1,566.2070
Net Interest Income
-4,971.6450
-5,473.2140
-5,007.4780
-3,221.6610
-1,672.8110
EBIT
17,773.0060
8,811.4500
10,828.7580
4,477.1450
38.0640
EBITDA
24,243.9020
15,164.2650
15,770.9040
8,397.7290
3,064.3530
Reconciled Cost of Revenue
49,523.5720
46,983.6400
26,048.8730
15,818.3650
4,729.9250
Reconciled Depreciation
6,470.8960
6,352.8150
4,942.1460
3,920.5840
3,026.2890
Net Income from Continuing Operation Net Minority Interest
13,398.2290
6,438.4840
6,945.4180
2,305.4190
-1,528.1430
Total Unusual Items Excluding Goodwill
1,887.7070
1,912.6720
-67.9850
551.4080
-154.5330
Total Unusual Items
1,887.7070
1,912.6720
-67.9850
551.4080
-154.5330
Normalized EBITDA
22,356.1950
13,251.5930
15,838.8890
7,846.3210
3,218.8860
Tax Rate for Calcs
0
0.0002
0
0.0003
0
Tax Effect of Unusual Items
26.2271
286.9008
0
144.5240
0
8/31/2021 - 1/14/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.4300
-8.51%
 
ROMJ.V Rubicon Organics Inc.
0.4500
0.00%
 
SBBC.V Simply Better Brands Corp.
0.9800
+2.08%
 
AYR-A.CN Ayr Wellness Inc.
0.3850
-7.23%
 
CANB.V CanadaBis Capital Inc.
0.0500
0.00%
 
XLY.TO Auxly Cannabis Group Inc.
0.0900
0.00%
 
DB.V Decibel Cannabis Company Inc.
0.0700
+7.69%
 
MDP.TO Medexus Pharmaceuticals Inc.
2.9200
+3.18%
 
TSND.TO TerrAscend Corp.
0.5000
-1.96%
 
OGI.TO Organigram Global Inc.
1.6400
+5.81%